Cyclooxygenase-2-selective antagonists do not inhibit growth of colorectal carcinoma cell lines

Cancer Letters

Volumn 122, Issue 1-2, 1998, Pages 25-30

  Murphy, Vincent J ^a   Yang, Zhiyu ^b   Rorison, Kristy A ^b   Baldwin, Graham S ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b University Department of Surgery   (Australia)

Author keywords

Colorectal carcinoma; Cyclooxygenase; NSAIDs

Indexed keywords

6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE; ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ENZYME INHIBITOR; IBUPROFEN; INDOMETACIN; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTAGLANDIN SYNTHASE INHIBITOR; SALICYLIC ACID; SULINDAC; SULINDAC SULFIDE;

ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL GROWTH; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG MECHANISM; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032498330     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00361-3     Document Type: Article

References (26)

1. Narisawa T., Sato M., Tani M., Kudo T., Takahashi T., Goto A. Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res. 41:1981;1954-1957.
2. Pollard M., Luckert P.H. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science. 214:1981;558-559.
3. Giardiello F.M., Hamilton S.R., Krush A.J., Piantadosi S., Hylind L.M., Celano P.et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med. 328:1993;1313-1316.
4. Boolbol S.K., Dannenberg A.J., Chadburn A., Martucci C., Guo W., Ramonetti J.T.et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res. 56:1996;2556-2560.
5. Kune G.A., Kune S., Watson L.F. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne colorectal cancer study. Cancer Res. 48:1988;4399-4404.
6. Thun M.J., Namboodiri M.M., Calle E.E., Flanders W.D., Heath C.W. Aspirin use and risk of fatal cancer. Cancer Res. 53:1993;1322-1327.
7. Hixson L.J., Alberts D.S., Krutzsch M., Einsphar J., Brendel K., Gross P.H.et al. Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells. Cancer Epidemiol. Biomarkers Prevention. 3:1994;433-438.
8. Shiff S.J., Qiao L., Tsai L.-L., Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest. 96:1995;491-503.
9. Eberhart C.E., DuBois R.N. Eicosanoids and the gastrointestinal tract. Gastroenterology. 109:1995;285-301.
10. Mitchell J.A., Akarasereenont P., Thiemermann C., Flower R.J., Vane J.R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA. 90:1993;11693-11697.
11. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 107:1994;1183-1188.
12. Sano H., Kawahito Y., Wilder R.L., Hashiramoto A., Mukai S., Asai K.et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55:1995;3785-3789.
13. Reddy B.S., Rao C.V., Seibert K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventative properties in colon carcinogenesis. Cancer Res. 56:1996;4566-4569.
14. Hanif R., Pittas A., Feng Y., Koutsos M.I., Qiao L., Staiano-Coico L.et al. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol. 52:1996;237-245.
15. Rao C.V., Rivenson A., Simi B., Zang E., Kelloff G., Steele V.et al. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res. 55:1995;1464-1472.
16. Goldberg Y., Nassif I.I., Pittas A., Tsai L.-L., Dynlacht B.D., Rigas B.et al. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells - alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene. 12:1996;893-901.
17. Pasricha P.J., Bedi A., O'Connor K., Rashid A., Akhtar A.D., Zahurak M.L.et al. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology. 109:1995;994-998.
18. Piazza G.A., Kulchak Rahm A.L., Krutzsch M., Sperl G., Paranka N.S., Gross P.H.et al. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 55:1995;3110-3116.
19. Whitehead R.H., Macrae F.A., St. John D.J.B., Ma J. A colon cancer cell line (LIM 1215) derived from a patient with inherited nonpolyposis colorectal cancer. J. Natl. Cancer Inst. 74:1985;759-765.
20. Whitehead R.H., Zhang H.H., Hayward I.P. Retention of tissue-specific phenotype in a panel of colon carcinoma cell lines: relationship to clinical correlates. Immunol. Cell Biol. 70:1992;227-236.
21. Futaki N., Takahashi S., Yokoyama M., Arai I., Higuchi S., Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins. 47:1994;55-59.
22. Chan C.-C., Boyce S., Brideau C., Ford-Hutchinson A.W., Gordon R., Guay D.et al. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745 337: a novel non-steroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J. Pharm. Exp. Ther. 274:1995;1531-1537.
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
24. Baldwin G.S., Zhang Q.-X. Measurement of gastrin and transforming growth factor α mRNA levels in colonic carcinoma cell lines by quantitative polymerase chain reaction. Cancer Res. 52:1992;2261-2267.
25. Hla T., Neilson K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA. 89:1992;7384-7388.
26. Takahashi T., Ueda N., Yoshimoto T., Yamanoto S., Yokoyama C., Miyata A.et al. Immunoaffinity purification and cDNA cloning of human platelet prostaglandin endoperoxide synthase (cyclooxygenase). Biochem. Biophys. Res. Commun. 182:1992;433-438.